Calliditas Therapeutics
CALT
#5361
Rank
ยฃ0.83 B
Marketcap
ยฃ30.54
Share price
-0.10%
Change (1 day)
106.97%
Change (1 year)

Operating Margin for Calliditas Therapeutics (CALT)

Operating Margin as of October 2024 (TTM): -22.04%

According to Calliditas Therapeutics's latest financial reports and stock price the company's current Operating Margin is -22.04%. At the end of 2022 the company had an Operating Margin of -50.99%.

Operating Margin history for Calliditas Therapeutics from 2020 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2022-50.99%-77.22%
2021-223.84%-99.55%
2020-49,902.86%283691.14%
2019-17.58%

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.